Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Total Current Liabilities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Total Current Liabilities for 9 consecutive years, with $5.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 105.92% to $5.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.3 million, a 105.92% increase, with the full-year FY2024 number at $2.2 million, down 9.79% from a year prior.
  • Total Current Liabilities was $5.3 million for Q3 2025 at Catheter Precision, up from $4.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $7.6 million in Q4 2022 to a low of $2.0 million in Q3 2023.
  • A 5-year average of $3.9 million and a median of $3.6 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: plummeted 67.37% in 2023, then surged 105.92% in 2025.
  • Catheter Precision's Total Current Liabilities stood at $5.4 million in 2021, then soared by 40.56% to $7.6 million in 2022, then tumbled by 67.37% to $2.5 million in 2023, then dropped by 9.79% to $2.2 million in 2024, then soared by 138.79% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Total Current Liabilities are $5.3 million (Q3 2025), $4.6 million (Q2 2025), and $4.1 million (Q1 2025).